Correlation Between Anebulo Pharmaceuticals and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Immix Biopharma, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Immix Biopharma.
Diversification Opportunities for Anebulo Pharmaceuticals and Immix Biopharma
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Anebulo and Immix is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Immix Biopharma go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Immix Biopharma
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.18 times more return on investment than Immix Biopharma. However, Anebulo Pharmaceuticals is 1.18 times more volatile than Immix Biopharma. It trades about -0.05 of its potential returns per unit of risk. Immix Biopharma is currently generating about -0.14 per unit of risk. If you would invest 163.00 in Anebulo Pharmaceuticals on November 9, 2024 and sell it today you would lose (9.00) from holding Anebulo Pharmaceuticals or give up 5.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Immix Biopharma
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Immix Biopharma |
Anebulo Pharmaceuticals and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Immix Biopharma
The main advantage of trading using opposite Anebulo Pharmaceuticals and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |